Literature DB >> 26608090

Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

S Vallabhaneni1, O Almendares2, M M Farley3, J Reno2, Z T Smith2, B Stein2, S S Magill4, R M Smith5, A A Cleveland5, F C Lessa4.   

Abstract

We assessed prevalence of and risk factors for candidaemia following Clostridium difficile infection (CDI) using longitudinal population-based surveillance. Of 13 615 adults with CDI, 113 (0·8%) developed candidaemia in the 120 days following CDI. In a matched case-control analysis, severe CDI and CDI treatment with vancomycin + metronidazole were associated with development of candidaemia following CDI.

Entities:  

Keywords:  CDI treatment; Candidaemia; Clostridium difficile infection; co-infection; severe CDI

Mesh：

Substances：

Year:  2015        PMID： 26608090      PMCID： PMC9150584          DOI： 10.1017/S0950268815003027

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   4.434


  12 in total

1.  Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.

Authors:  Marco Falcone; Alessandro Russo; Federica Iraci; Paolo Carfagna; Paola Goldoni; Vincenzo Vullo; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Candidemia subsequent to severe infection due to Clostridium difficile: is there a link?

Authors:  Maurizio Guastalegname; Alessandro Russo; Marco Falcone; Simone Giuliano; Mario Venditti
Journal:  Clin Infect Dis       Date:  2013-05-30       Impact factor: 9.079

3.  Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.

Authors:  Cirle A Warren; Edward J van Opstal; Mary S Riggins; Yuesheng Li; John H Moore; Glynis L Kolling; Richard L Guerrant; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

4.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

Authors:  Angela Ahlquist Cleveland; Monica M Farley; Lee H Harrison; Betsy Stein; Rosemary Hollick; Shawn R Lockhart; Shelley S Magill; Gordana Derado; Benjamin J Park; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2012-08-14       Impact factor: 9.079

5.  Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.

Authors:  A Russo; M Falcone; M Fantoni; R Murri; L Masucci; P Carfagna; M C Ghezzi; B Posteraro; M Sanguinetti; M Venditti
Journal:  Clin Microbiol Infect       Date:  2015-01-14       Impact factor: 8.067

6.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

7.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

8.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

9.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

10.  Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.

Authors:  Michelle M Nerandzic; Kathleen Mullane; Mark A Miller; Farah Babakhani; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079
View more
  5 in total

1.  A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia.

Authors:  Sharon Tsay; Sabrina R Williams; Kaitlin Benedict; Zintars Beldavs; Monica Farley; Lee Harrison; William Schaffner; Ghinwa Dumyati; Anna Blackstock; Alice Guh; Snigdha Vallabhaneni
Journal:  Clin Infect Dis       Date:  2019-02-01       Impact factor: 9.079

2.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 3.  Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options.

Authors:  Mattia Trunfio; Silvia Scabini; Walter Rugge; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Microorganisms       Date:  2022-06-23

4.  Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection.

Authors:  Alessandra Oliva; Lucia Aversano; Massimiliano De Angelis; Maria Teresa Mascellino; Maria Claudia Miele; Sergio Morelli; Riccardo Battaglia; Jessica Iera; Giovanni Bruno; Enrico Stefano Corazziari; Maria Rosa Ciardi; Mario Venditti; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  Open Forum Infect Dis       Date:  2019-12-03       Impact factor: 3.835

Review 5.  Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.

Authors:  Chia-Yu Chiu; Amara Sarwal; Addi Feinstein; Karen Hennessey
Journal:  Antibiotics (Basel)       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.